“Express Scripts, one of the nation’s leading pharmacy benefit managers, and Appriss Health, provider of the most comprehensive prescription drug monitoring platform for addressing substance use disorder (SUD) in the U.S., today announced the creation of a Prescription Drug Monitoring Program (PDMP) for the Military Health System (MHS). The MHS PDMP is now the 54th PDMP in the U.S., and the 44th PDMP operated by Appriss Health.”
“The MHS PDMP will help improve the safety of controlled substances by closing a critical information gap between Military Treatment Facilities (MTFs) and non-Military healthcare providers. It will allow community based prescribers at clinics, hospitals and local pharmacies to see if a Schedule II-V medication — such as an opioid, anabolic steroid, sleep medication or ADHD medication — was recently prescribed to their patient by another prescriber, including one at a Military Treatment Facility, in an effort to reduce potential abuse…”
“The Defense Health Agency (DHA) — a joint, integrated Combat Support Agency that supports the health and medical needs of the Unites States Armed Forces and oversees the MHS — tasked Express Scripts with creating the new MHS PDMP to close this information gap as part of its larger role administering the TRICARE Pharmacy Program’s outpatient pharmacy benefit. Express Scripts chose to partner with Appriss Health to design and deliver this innovative MHS PDMP to help identify, prevent and manage SUD within the MHS’ patient population…” Read the full article here.
Source: Express Scripts and Appriss Health Create New Military Health System Prescription Drug Monitoring Program – April 23, 2019. PR Newswire.
